ArticleCancer drug resistance (Alhambra, Calif.)2020

Can HIPEC be used against platinum-resistance and for inducing sensitivity to PARP inhibitors in ovarian cancer?

Thales Paulo Batista et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.